In case you missed it, PCMA President and CEO JC Scott testified before the U.S. House Education and the Workforce Committee Subcommittee on Health, Employment, Labor, and Pensions. During Scott’s testimony, he highlighted the critical role of pharmacy benefit companies in
(Washington, D.C.) — Senior registered voters enrolled in Medicare Part D will be less likely to support the reelection of their members of Congress and presidential candidates if those elected officials back proposals eliminating prescription drug negotiations and price concessions
New Milliman Analysis Shows Medicare Part D Proposed Rule Could Increase Premiums More than It Saves in Cost Sharing for Majority of Beneficiaries (Washington, D.C.) — A new report, “Medicare Part D Pharmacy Price Concessions at the Point of Sale, Potential Impacts
In case you missed it, Ike Brannon, senior fellow at the Jack Kemp Foundation and former senior economist for the United States Treasury and U.S. Congress, explains the problem with misguided policies targeting pharmacy benefit companies in a new RealClearMarkets
Senior Advisor, MedImpact Mr. Marsella is currently a Senior Advisor at MedImpact. He has more than 20 years of experience in healthcare and pharmacy benefit administration and management. He was promoted to Senior Vice President, Sales and Marketing at the
Casey Mulligan, Ph.D., professor of economics at the University of Chicago, member of the National Bureau of Economic Research (NBER), and former Chief Economist of the White House Council of Economic Advisers, testified before the U.S. Senate Committee on Commerce, Science, and Transportation during a hearing Thursday on S. 127.
As a reminder, the U.S. House of Representatives Committee on Oversight and Reform previously found, in a 2021 report, that PBM-negotiated rebates are not correlated with the list prices set by drug companies. The report also finds that “drug companies have
Dr. Patrick Conway CEO, Optum Rx Patrick Conway, MD, MSc, was named chief executive officer of Optum Rx in August 2023. In this role he leads an integrated pharmacy care services organization that is making drugs more affordable and creating
PCMA President and CEO Testifying Today on Importance of Preserving Employer Choice and Contracting Flexibility (Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement today ahead of JC Scott, President and CEO of PCMA, testifying before
©2024 PCMA. All Rights Reserved.
